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doi:10.1Objective: The objectives of this study were (1) to determine the use of temporary epicardial pacing wires to
diagnose and treat early postoperative arrhythmias in pediatric cardiac surgical patients and (2) to determine
the predictive factors for the need of pacing wires for diagnostic or therapeutic purposes.
Methods: We collected preoperative, intraoperative, and postoperative data in a prospective, observational
format from patients undergoing pediatric cardiac surgery between August 2010 and January 2011 at a single
academic children’s hospital.
Results: A total of 157 patients met the inclusion criteria during the study period. Of these 157 patients, pacing
wires were placed in 127 (81%). Pacing wires were used in 25 patients (19.6%) for diagnostic purposes, 26
patients (20.4%) for therapeutic purposes, 15 patients (11.8%) for both diagnostic and therapeutic purposes,
and 36 patients (28.3%) for diagnostic or therapeutic purposes. Need for cardioversion in the operating
room, presence of 2 or more intracardiac catheters, severely reduced ventricular ejection fraction, and elevated
serum lactate level at the time of operating room dischargewere found to be independent predictors for the use of
pacing wires. The only complication noted in the cohort was a skin infection at a pacing wire insertion site in
1 patient. A permanent pacemaker was required in 8 (6.2%) of all patients with temporary pacing wires.
Conclusions: Our data support the use of temporary epicardial pacing wires in approximately 30% of children
after congenital heart surgery. We found the need for cardioversion in the operating room, presence of 2 or more
intracardiac catheters, severely reduced ventricular ejection fraction, and high serum lactate level at the time of
discharge from the operating room to be independent predictors of the use of pacing wires in the early postop-
erative period. (J Thorac Cardiovasc Surg 2012;144:557-62)Earn CME credits at
http://cme.ctsnetjournals.org
Arrhythmias are a well-known complication after cardiac
surgery in children with congenital heart defects.1-4
Temporary epicardial pacing wires are used in the
perioperative period both for diagnosis of arrhythmias and
for treatment of a variety of abnormalities of cardiac
rhythm. Some centers have advocated for discontinuing
the routine placement of temporary pacing wires.5 The ar-
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The Journal of Thoracic and Cawires are associated with serious postoperative complica-
tions, and the incidence of postoperative arrhythmias and
heart block are now low because of improvements in myo-
cardial protection and surgical techniques. The data on the
complications associated with the use and removal of pac-
ing wires are limited, with isolated case reports describing
events, including cardiac perforation, tamponade, foreign
body retention, wire migration, and wire-induced arrhyth-
mias.6-13 In contrast, other centers have demonstrated the
routine use of temporary pacing wires without major
complications.14,15 Attempts to define predictors for the use
of pacing wires after pediatric cardiac surgery have also
been made.14,15 Moltedo and colleagues14 demonstrated the
length of cardiopulmonary bypass (CPB) and aortic cross-
clamp time to be predictors of the need for pacing wires after
pediatric cardiac surgery. By using hemodynamic improve-
ment as the primary outcome, Ceresnak and colleauges15
demonstrated that the occurrence of intraoperative arrhyth-
mias, use of circulatory arrest, and Fontan procedure were
independent predictors for hemodynamic improvement with
postoperative pacing.
Because of the conflicting recommendations and limited
published data on this topic, we prospectively evaluated
our institutional experience with the use of temporary epi-
cardial pacing wires in pediatric cardiac surgical patients.
The purpose of our study was to determine the following:rdiovascular Surgery c Volume 144, Number 3 557
Abbreviations and Acronyms
CPB ¼ cardiopulmonary bypass
TEE ¼ transesophageal echocardiogram
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D(1) the use of pacing wires to diagnose or treat early post-
operative arrhythmias, (2) the predictive factors for the
need of temporary epicardial wires, and (3) the complica-
tions associated with the use or removal of temporary
pacing wires.MATERIALS AND METHODS
We performed a prospective, observational study with patients admitted
to Stanford University’s pediatric cardiovascular intensive care unit. The
institutional review board of the Stanford University Medical Center ap-
proved the study, and the need for informed consent was waived. All pa-
tients aged 1 day to 18 years undergoing surgical repair or palliation of
congenital heart defects from August 2010 to January 2011 at Lucile Pack-
ard Children’s Hospital were included in the study. The primary outcome
variable evaluated in our study was the use of temporary epicardial pacing
wires for diagnostic or therapeutic purposes, or both. Patients who under-
went ligation of patent ductus arteriosus, repair of coarctation of aorta via
lateral thoracotomy, and implantation of a permanent pacemaker as a pri-
mary procedure were excluded. The decision to implant temporary atrial or
ventricular epicardial pacing wires was made by the cardiac surgical team
in the operating room, and the decision to use and remove the pacing wires
was made jointly by the cardiac intensive care and surgical teams. The di-
agnostic uses of pacing wires included evaluation of the cardiac rhythm and
the diagnosis of tachyarrhythmias and bradyarrhythmias. The use of pacing
wires for diagnostic purposes was typically prompted by inadequate infor-
mation on surface electrocardiogram recordings. The therapeutic uses of
pacing wires included increasing the heart rate to augment blood pressure,
establishing atrioventricular synchrony, performing overdrive pacing of
junctional rhythms, suppressing ectopy, and terminating tachyarrhythmias.
The use of pacing wires for therapeutic purposes was typically due to
hemodynamic instability or signs and symptoms of low cardiac output
syndrome (eg, inadequate urine output, low mixed venous oxygen satura-
tion, elevated serum lactate, or metabolic acidosis).
Sinus bradycardia, junctional ectopic tachycardia, complete heart
block, slow junctional rhythm, supraventricular and ventricular tachycar-
dias, atrial flutter and atrial fibrillation, sinus tachycardia, frequent prema-
ture atrial, or ventricular complexes were considered critical arrhythmias.
Sinus bradycardia was defined as an inadequate sinus rate for the age and
hemodynamic condition of the patient or as a junctional escape rhythm in
the absence of atrioventricular block or junctional ectopic tachycardia. The
following minimal rates according to age were considered as bradycardia:
120 to 130 beats/min diurnal rate in neonates, less than 120 beats/min in
children aged less than 1 year, 110 beats/min in children aged 3 to 4 years,
100 beats/min in children aged 5 to 7 years, less than 90 beats/min in
children aged 8 to 11 years, and 85 beats/min in children aged 12 to
15 years.3,16,17 Sinus tachycardia was defined as heart rate more than 180
beats/min in children aged less than 2 years and more than 160 beats/min
in children aged more than 2 years. Frequent premature supraventricular
or ventricular beats were diagnosed if their number exceeded 10 per minute.3
We collected preoperative variables, including age, sex, weight, degree
of prematurity, need for preoperative medications, need for antiarrhythmic
medications, thyroid disease, preoperative cardiomegaly, cardiac diagno-
sis, and diagnosis of trisomy 21 and 22q11 microdeletion. Risk adjustment
for surgery was performed using the Risk Adjustment for Congenital Heart558 The Journal of Thoracic and Cardiovascular SurgSurgery-1 method.18 Intraoperative data included the procedure performed,
CPB time, aortic crossclamp time, need for pacing coming off CPB, need
for cardioversion or defibrillation in the operating room, volume of blood
products administered, site of incision(s) (atrial, ventricular, or both), intra-
operative ST-segment changes, and use of any antiarrhythmic medications.
Postoperative variables included serum lactate level; ventricular ejection
fraction on immediate postoperative transesophageal echocardiogram
(TEE); inotrope score19; number and location of intracardiac catheters;
dexemedetomidine use at the time of onset of arrhythmia; electrolyte ab-
normality as measured by potassium, calcium, and magnesium levels; se-
rum lactate level; body temperature; arterial pH and inotrope score19 at
the time of onset of any arrhythmia; need and use of pacing wires for diag-
nostic or therapeutic purposes or both; duration of pacingwire implantation
and of mechanical ventilation; and complications associated with use and
removal of pacing wires, including death. The cardioplegia in our patients
was standardized and induced using a solution of Plegisol (Hospira, Inc,
Lake Forest, Ill) (sodium: 110 mEq/L, chloride: 160 mEq/L, potassium:
16 mEq/L, calcium: 2.4 mEq/L, magnesium: 32 mEq/L), with additional
additives of potassium chloride (5 mEq/L) and sodium bicarbonate
(10 mEq/L). Qualitatively reduced ejection fraction on postoperative
TEE as judged by an independent, experienced echocardiographer consti-
tuted reduced ejection fraction for the purposes of study. Cardiomegaly was
defined as a transverse diameter of the cardiac silhouette greater than or
equal to 50% of the transverse diameter of the chest (increased cardiotho-
racic ratio) and was judged by an independent, experienced radiologist.
The complications assessed included transmyocardial migration of
a wire, cardiac perforation, pericardial effusion, cardiac tamponade, ar-
rhythmias associated with removal of pacing wires, and retention of pacing
wires after attempted removal. Patient charts, telemetry recordings, and
electrocardiograms were reviewed for all patients included. In addition,
we reviewed chest radiographs to assess the position of temporary pacing
wires, as well as all echocardiograms performed after the removal of pacing
wires to assess for pericardial effusion.
Statistical Analysis
Continuous variables are presented asmedian (10th percentile, 90th per-
centile), and categoric variables are presented as counts and percentages.
We performed univariable analyses to examine the associations between
the patient characteristics and risk factors and the primary outcome vari-
able. The P value was calculated using Pearson’s chi-square test or Fisher
exact test of independence for categoric variables and Wilcoxon rank-sum
test for continuous variables. We also completed a redundancy analysis of
the candidate predictors for multivariate logistic regression models along
with variable clustering using Hoeffding’s D statistic. A multivariable
logistic regression analysis was performed to identify possible predictors
associated with the need for pacing wires. Variables with a P value of .2
or less in the univariate analysis were entered in the multiple regression
model. Any variable with 20% or more missing values or that occurred un-
commonly (5 subjects) was not considered for inclusion in the multivar-
iate analyses. The model was expressed in terms of adjusted odds ratio,
95% confidence interval, and P value. Backward variable selection was
used to help select variables. We performed several additional analyses
to explore the findings of the multivariate model and investigate variables
not selected. The model’s goodness-of-fit was evaluated using the Hosmer–
Lemeshow test, and the ability of the model to discriminate between
outcomes was assessed using the c-statistic (which is equal to the area un-
der the receiver operating curve). All analyses were performed using
STATA/MP, Version 11.1 biostatistical software (StataCorp LP, College
Station, Tex).RESULTS
A total of 157 patients met the inclusion criteria during
the study period. Of these 157 patients, pacing wires wereery c September 2012
TABLE 1. Incidence of types of cardiac arrhythmias corresponding to use of temporary epicardial pacing wires
Type of arrhythmia Incidence of arrhythmia
Use of pacing wires
Diagnostic Therapeutic Both Either
Junctional ectopic tachycardia 9 5 9 5 9
Complete heart block 7 4 7 4 7
Slow junctional rhythm 5 5 5 5 5
Supraventricular tachycardia 3 2 1 – 3
Atrial flutter/atrial fibrillation 4 2 2 1 3
Sinus bradycardia 2 – 2 – 2
Sinus tachycardia 4 4 – – 4
Premature atrial complexes 4 3 – – 3
Premature ventricular complexes 2 – – – –
Ventricular tachycardia/ventricular fibrillation 2 – – – –
Total 42 25 26 15 36
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Dplaced in 127 (81%). Among those with the pacing wires,
82 (64.5%) had only atrial pacing wires, 21 (16.5%) had
only ventricular pacing wires, and 24 (18.8%) had both
atrial and ventricular pacing wires. The incidence of ar-
rhythmias was 33% (42 patients). Pacing wires were used
in 25 patients (19.6%) for diagnostic purposes, 26 patients
(20.4%) for therapeutic purposes, 15 patients (11.8%) for
both diagnostic and therapeutic purposes, and 36 patients
(28.3%) for diagnostic or therapeutic purposes (Table 1).
Patients’ types of surgical repair are listed in Table 2. Pa-
tients not receiving temporary pacing wires did well during
their postoperative course and did not need any further acute
electrophysiologic intervention during their hospital stay.
Patients receiving pacing for therapeutic reasons had im-
provement in hemodynamics after initiation of pacing.
Two patients had evidence of slow junctional rhythm during
the use of dexemedetomidine. Sequential atrioventricular
pacing was used to increase the heart rate to promote hemo-
dynamic stability. The mean  standard deviation inotrope
score, arterial pH, and body temperature at the time of ini-
tiation of pacing in subjects who needed pacing forTABLE 2. Type of surgical repair
Total patients eligible for inclusion in the study 157
Patients with no epicardial pacing wires
Patent ductus arteriosus repair 15
Coarctation of aorta repair 12
Implantation of permanent pacemaker 3
Patients with implantation of epicardial pacing wires
Single ventricle palliation: Norwood, Glenn,
Fontan, central shunt
26
Septal defect (ASD/VSD) 26
TOF repair 22
Atrioventricular septal defect: complete and partial 14
Anomalous pulmonary venous connection: total and partial 8
Arterial switch operation 4
Others* 27
ASD, Atrial septal defect; TOF, tetralogy of Fallot; VSD, ventricular septal defect.
*Others include orthotopic heart transplantation, subaortic membrane resection,
mitral valve replacement, Ross procedure, Rastelli procedure, vascular ring repair,
septal myomectomy, and pulmonary artery plasty.
The Journal of Thoracic and Catherapeutic reasons were 12.4  4.3, 7.4  0.1, and
36.3C  1.0C, respectively. The mean  standard devia-
tionmagnesium, potassium, ionized calcium, and serum lac-
tate levels in the same patients at the time of initiation of
pacing were 2.5  0.7 mEq/L, 3.6  0.7 mEq/L, 1.3  0.3
mmol/L, and 3.1  0.9 mmol/L, respectively. None of the
patients needing pacing had abnormal electrolytes at the
time of initiation of pacing, whereas 8 patients had lactate
acidosis (4 mmol/L) at the time of initiation of pacing.
The lactic acidosis improved to normal limits in 3 patients
within the first 4 hours, 2 patients within the first 8 hours,
and 3 patients within the first 12 hours of initiation of pacing.
We divided our cohort into 2 groups: one group in whom
pacing wires were used for diagnostic or therapeutic pur-
poses and one group in whom pacing wires were never
used. Baseline demographics were similar in both groups
(Table 3). On univariate analysis comparing the 2 groups,
the variables associated with the use of pacing wires (P 
.05) included preoperative cardiomegaly, need for cardio-
version in the operating room, pacing required to come
off CPB, presence of 2 or more intracardiac catheters, se-
verely reduced ventricular ejection fraction on the postoper-
ative TEE, elevated serum lactate level, higher inotrope
score, and use of antiarrythmics leaving the operating
room (Table 2). Other variables with a P value of .2 or
less included in the subsequent multivariate analysis were
body weight, mean CPB time, volume of blood products ad-
ministered in the operating room, and presence of single
ventricle physiology. In the multivariate analysis, the need
for cardioversion in the operating room, presence of 2 or
more intracardiac catheters, severely reduced ventricular
ejection fraction on TEE, and elevated serum lactate level
at the time of operating room discharge were found to be in-
dependent predictors for the use of pacing wires (Table 4).
The model had adequate goodness of fit with a nonsignifi-
cant Hosmer–Lemeshow P¼ .45. The c-statistic or area un-
der the receiver operating curvewas 0.86, indicating that the
model had good discrimination. The redundancy analysis of
the candidate predictors for multivariate logistic regressionrdiovascular Surgery c Volume 144, Number 3 559
TABLE 3. Univariable analyses of potential risk factors for the need of diagnostic or therapeutic use of temporary pacing wires
Variable Need for pacing wires (n ¼ 36) No need for pacing wires (n ¼ 91) P value
Age (mo) 7.5 (0.2–117.0) 14.0 (0.2–143.0) .22
Male sex 44% (16) 52% (47) .46
Premature (<36 wk) 11% (4) 9% (8) .74*
Weight (kg) 6.6 (2.8–28.4) 8.4 (3.1–32.4) .14
Preoperative antiarrhythmics 6% (2) 5% (5) 1.00*
Thyroid disease 0% (0) 2% (2) 1.00*
Preoperative cardiomegaly 89% (32) 71% (63) .03
Trisomy 21 8% (3) 5% (5) .69*
DiGeorge syndrome 3% (1) 3% (3) 1.00*
RACHS-I classification (category 4–6) 28% (10) 21% (19) .4
Single ventricle anatomy 31% (11) 16% (15) .07
Inotrope score at onset of arrhythmiay 11.8 (7.0–17.5) 10.5 (3.0–17.5) .05
Mean CPB time (min) 118.5 (0.0–303.0) 98.0 (0.0–215.0) .18
Aortic crossclamp time (min) 60.0 (0.0–117.0) 42.5 (0.0–113.5) .28
Pacing required to come off CPB 33% (12) 4% (4) <.001*
Cardioversion required in OR 33% (12) 7% (6) <.001
Antiarrythmics leaving the OR 39% (14) 2% (2) <.001*
Amount of blood products in OR (mL/kg) 38.5 (15.0–107.0) 26.7 (5.6–97.0) .08
2 intracardiac catheters 33% (12) 9% (8) <.001
Perioperative ST–segment changes 0% (0) 4% (4) .58
Postoperative lactate levels 3.4 (2.2–7.0) 2.3 (1.4–4.5) <.001
Post-bypass TEE reduced ejection fraction 45% (14) 8% (7) <.001
Ventricular incision 22% (8) 22% (20) .98
Atrial incision 72% (26) 67% (61) .57
Atrial and ventricular incisions 19% (7) 11% (10) .21
Dexmedetomidine use at the time of onset of pacing 6% (2) 0% (0) .084*
No. of days with pacing wires 10.5 (5.0–49.0) 6.0 (3.0–15.5) <.001
Days of mechanical ventilation 3.0 (1.0–27.0) 1.0 (1.0–6.0) <.001
Death 6% (2) 0% (0) .084*
OR, Operating room; CPB, cardiopulmonary bypass; RACHS-1, Risk Adjustment for Congenital Heart Surgery-1; TEE, transesophageal echocardiogram. *Fisher exact test P
value reported. Continuous variables are summarized by the median (10th, 90th percentiles). Categoric variables are summarized as percent (n). yInotrope score19: dosages of
dopamineþdobutamine (in mg/kg/min)þ (dosages of epinephrineþnorepinephrineþ isoproterenol [in mg/kg/min]) 3 100þdosages of milrinone (in mg/kg/min) 3 15.
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Dmodels found no redundant variables. Patients in the group
with use of pacing wires remained tracheally intubated and
had their pacing wires in place for a longer period of time.
There was no difference in the incidence of death in the 2
groups associated with the use or removal of pacing wires.
One patient had a skin infection associated with a pacing
wire. We observed no other complications associated with
use or removal of pacing wires. A permanent pacemaker
was required in 8 patients (6%) with temporary pacingwires.
Of all the patients whowere admitted to the cardiac inten-






Postoperative reduced ejection fraction 4.9 1.2 20.1 .03
Postoperative lactate 1.6 1.1 2.3 .008
Intracardiac lines  2 4.5 1.1 19.1 .04
Mean CPB time (min) 1.0 1.0 1.0 .08
Cardioversion required in OR 8.2 2.0 33.8 .004
CI, Confidence interval; OR, odds ratio.
560 The Journal of Thoracic and Cardiovascular Surgcatheter, and 20 had 2 or more intracardiac catheters. In the
cohort of 107 children with 0 or 1 intracardiac catheter, pac-
ing wires were used for diagnostic purposes in 14 patients
(13%), therapeutic purposes in 19 patients (18%), and di-
agnostic or therapeutic purposes or both in 24 patients
(22%). In the cohort of 20 children with 2 or more intracar-
diac catheters, pacing wires were used for diagnostic pur-
poses in 11 patients (55%), therapeutic purposes in 7
patients (35%), and diagnostic or therapeutic purposes or
both in 12 patients (60%) (Figure 1). Atrial arrhythmias
were noted in 8 of 20 patients (40%) with 2 or more intra-
cardiac catheters and in 3 of 107 patients (3%) with 0 or
1 intracardiac catheter. Junctional ectopic tachycardia, the
other common arrhythmia, was noted in 5 of 20 patients
(25%) with 2 or more intracardiac catheters and in 4 of
107 patients (4%) with 0 or 1 intracardiac catheter.DISCUSSION
Temporary epicardial pacing wires have traditionally
been placed in children as a routine practice after most or
all intracardiac surgical procedures for congenital heartery c September 2012
FIGURE 1. Comparison of the use of pacing wires as a function of the
number of intracardiac catheters.
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the utility, safety, and predictors of the need for pacing wires
after cardiac surgery in children. The reported incidence of
postoperative arrhythmias ranges from 14% to 29% in pe-
diatric patients with cardiac disease.1-4,14,15 Most published
studies report higher complexity of surgery, longer CPB
time, longer aortic crossclamp time, lower body weight,
and repair of atrioventricular septal defects to be
associated with arrhythmias in children after intracardiac
surgery.1-4,14,15 Despite this incidence of arrhythmias,
Fishberger and colleagues5 advocated against the routine
placement of temporary pacing wires after pediatric cardiac
surgery. In their cohort of 1193 surgical procedures, tempo-
rary pacing wires were implanted in 14 children (1.2%) and
used in only 4 patients (0.3%). In contrast, Moltedo and
colleagues14 reported the use of temporary pacing wires
in 35% of their patients for diagnostic or therapeutic rea-
sons.14 By using hemodynamic improvement as the primary
outcome, Ceresnak and colleagues15 found pacing wires to
be useful in 20% of a cohort of 117 patients, and a total of
35 patients (30%) were paced.
Although the incidence of arrhythmiaswas 33% in our co-
hort, 20% of our patient population received temporary pac-
ing. Pacing wires were used in 28% of our patients for
diagnostic or therapeutic purposes.Greater disease complex-
ity as defined by higher Risk Adjustment for Congenital
Heart Surgery-1 category (groups 4–6), younger age, smaller
size, need for greater blood product transfusion in the operat-
ing room, and single ventricle anatomy were not found to be
independent predictors for the need of pacing wires. Al-
though we suspected that electrolyte abnormalities would
be present at the time of the onset of arrhythmias,1,20,21 we
found normal levels of potassium, ionized calcium, and
magnesium at the time of initiation of pacing. Lactic
acidosis improved with initiation of pacing in our cohort,
reiterating the fact that the use of pacing wires is associated
with hemodynamic improvement.15 The presence of 2 or
more intracardiac catheters was independently associated
with the use of pacing wires. Although intracardiac cathetersThe Journal of Thoracic and Caare relatively safe,22,23 they may be associated with
mechanical irritation and increased ectopy, which may
have contributed to arrhythmias in this patient population.Study Limitations
Our study has several limitations. First, this is a single-
center study and the results may not be generalizable to
all centers, because surgical and postoperative medical
management vary from one institution to another. Second,
the decision to use pacing wires for diagnostic or therapeu-
tic purposes was made by the treating physicians, and this
may have introduced some ascertainment bias in the study.
Third, the patients whose pacing wires were used had higher
serum lactate levels and evidence of worse ventricular
function after surgery, suggesting they were sicker than
the patients who did not have their pacing wires used.
Fourth, because of insufficient end points, we could not
evaluate the use of atrial and ventricular pacing wires sepa-
rately. Despite these limitations, our study helps to lay the
foundation for future prospective, randomized multicenter
trials of temporary pacing wire use.CONCLUSIONS
Our data support the use of temporary epicardial pacing
wires in approximately 30% of children after congenital
heart surgery. We found the need for cardioversion in the
operating room, presence of 2 or more intracardiac cathe-
ters, severely reduced ventricular ejection fraction, and
high serum lactate level at the time of discharge from the
operating room to be independent predictors of the use of
pacing wires in the early postoperative period.References
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